**Question:** The drug used in Alzheimer's disease is

A. Cholinesterase inhibitors
B. Memantine
C. Cognitive enhancers
D. Antidepressants

**Correct Answer:** **B. Memantine**

**Core Concept:** Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline, memory loss, and behavioral abnormalities. The primary pathological hallmarks of AD include extracellular amyloid-beta plaques and intracellular neurofibrillary tangles, resulting in neuronal dysfunction and loss. Alzheimer's disease can be classified into two main stages: mild cognitive impairment (MCI) and dementia.

**Why the Correct Answer is Right:** Memantine is a N-methyl-D-aspartate (NMDA) receptor antagonist, which helps to modulate glutamate neurotransmission in the brain. Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS) and is involved in synaptic plasticity, learning, and memory. Overactivation of NMDA receptors contributes to excitotoxicity, oxidative stress, and inflammation, which play a role in neuronal damage and death in Alzheimer's disease. By blocking NMDA receptors, memantine protects neurons from excitotoxicity and helps to slow down the progression of the disease.

**Why Each Wrong Option is Incorrect:**

A. Cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) are primarily used in Alzheimer's disease to improve cognitive function by inhibiting the breakdown of acetylcholine, a key neurotransmitter involved in learning, memory, and cognitive function. However, memantine is more effective when used in combination with cholinesterase inhibitors.

B. Antidepressants (such as selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and tricyclic antidepressants) are primarily used to treat mood disorders and do not specifically target Alzheimer's disease pathology. Memantine is the appropriate drug for Alzheimer's disease treatment due to its distinct mechanism of action.

C. Cognitive enhancers (e.g., modafinil, armodafinil) are used to improve cognitive function and alertness but are not specific to Alzheimer's disease. Memantine is more suitable for Alzheimer's treatment due to its target on NMDA receptors.

D. Memantine is not used for mild cognitive impairment (MCI) or Alzheimer's disease but is commonly used for Parkinson's disease and other neurodegenerative disorders. Cholinesterase inhibitors are the primary medications for Alzheimer's disease and mild cognitive impairment.

**Clinical Pearls:**

1. Alzheimer's disease is a complex neurological disorder involving multiple mechanisms, including oxidative stress, inflammation, and neurotransmitter imbalances, which explains the choice of using memantine as a complementary therapy to cholinesterase inhibitors.
2. Combining memantine with cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) is a common therapeutic strategy for Alzheimer's disease because it targets different